Acute Kidney Failure Clinical Trial
Official title:
The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
The primary objective is to safely determine if the investigators can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled the investigators will draw blood and urine for novel and standard biomarkers. The investigators are attempting to determine if these biomarkers can forecast the course of AKI (need for dialysis, death and renal recovery). The investigators seek to determine how well physicians caring for those with AKI can predict the clinical course compared to these novel biomarkers of AKI and if there is an association between clinical course and 3 year patient outcomes.
AKI is a very common disease in the setting of critical illness and carries an extremely high morbidity and mortality rate (over 50%). Currently there are no FDA approved therapeutic agents for the treatment of AKI. There is limited prospective evidence to guide nephrologists in terms of which patients will progress to more severe AKI in the setting of early AKI. Similarly, there is no evidence to guide nephrologists in terms of which patients will completely recover their renal function after AKI. Thus we need to know very early in the course of AKI which patients will progress and go on to require renal replacement therapy (RRT). Additionally we will investigating the long term patient outcomes, 2-3 years after the index AKI admission. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT00760591 -
Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study)
|
N/A | |
| Completed |
NCT00890214 -
Prostacyclin's Effect on Platelet Responsiveness
|
Phase 4 | |
| Active, not recruiting |
NCT03675906 -
The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
|
||
| Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
| Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
| Recruiting |
NCT00424320 -
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
|
Phase 3 | |
| Completed |
NCT00472563 -
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT03846258 -
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
|
Phase 4 | |
| Completed |
NCT06358365 -
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
|
N/A | |
| Completed |
NCT00252200 -
BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.
|
Phase 1/Phase 2 | |
| Completed |
NCT04190979 -
Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)
|
N/A | |
| Completed |
NCT04917497 -
Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
|
||
| Recruiting |
NCT05309291 -
Theranova Randomized, Controlled, Trial (RCT) in China
|
N/A | |
| Completed |
NCT02486614 -
Effect of Citrate on the Coagulation System in Patients Receiving CRRT
|
||
| Active, not recruiting |
NCT02470507 -
Immune Function in Acute Kidney Injury
|
||
| Active, not recruiting |
NCT05384899 -
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
|
||
| Completed |
NCT06190522 -
Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
|
||
| Recruiting |
NCT04221932 -
Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
|
||
| Active, not recruiting |
NCT01122225 -
Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury
|
N/A | |
| Completed |
NCT00529139 -
Hannover Dialysis Outcome Study
|
Phase 4 |